diosgenin has been researched along with Atherogenesis in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (58.33) | 24.3611 |
2020's | 5 (41.67) | 2.80 |
Authors | Studies |
---|---|
Bao, R; Chen, B; Chen, Q; Han, L; Liu, M; Pan, J; Wang, D; Wang, T; Wang, W; Wu, Y; Yu, H; Zhang, Y | 1 |
Wang, D; Wang, X | 1 |
Jin, Y; Liu, K; Ma, X; Sun, H; Wang, C; Wang, J; Xie, T; Yang, Q | 1 |
Jiang, JG; Wu, FC | 1 |
Binesh, A; Devaraj, H; Devaraj, SN | 2 |
Li, Y; Wang, M; Yang, T | 1 |
Sun, B; Xiao, J; Yang, D; Yin, YZ | 1 |
He, LY; Li, RL; Shen, GD; Wang, P; Yang, JL | 1 |
Cayabyab, FS; He, PP; Li, L; Liu, D; Lv, YC; Ouyang, XP; Tan, YL; Tang, CK; Tang, YY; Xie, W; Yang, J; Yao, F; Zhang, M; Zheng, XL | 1 |
Moura, ML; Pereira de Oliveira, A; Rolim, HM | 1 |
Fan, MJ; Hsieh, WT; Liu, FC; Pan, CH; Sheu, MJ; Tsai, CH; Wu, CH | 1 |
3 review(s) available for diosgenin and Atherogenesis
Article | Year |
---|---|
Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis.
Topics: Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Diosgenin; Humans; Inflammation | 2022 |
Effects of diosgenin and its derivatives on atherosclerosis.
Topics: Animals; Atherosclerosis; Dioscorea; Diosgenin; Endothelium, Vascular; Humans; Plant Extracts; Trigonella | 2019 |
Cardioprotector Activity of an Esteroidal Saponin: A Scientific and Technological Prospection.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cardiotonic Agents; Diosgenin; Disease Models, Animal; Dyslipidemias; Humans; Hypertension; Mice; Patents as Topic; Rats; Saponins | 2017 |
9 other study(ies) available for diosgenin and Atherogenesis
Article | Year |
---|---|
Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Diosgenin; Hyperuricemia; Liver; Mice; Signal Transduction | 2022 |
Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Cells, Cultured; Diosgenin; Endothelial Cells; Estrogen Receptor alpha; Female; Humans; Inflammation; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Ovariectomy; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Plant Extracts; Postmenopause; Receptors, LDL; Signal Transduction | 2019 |
Expression of chemokines in macrophage polarization and downregulation of NFκB in aorta allow macrophage polarization by diosgenin in atherosclerosis.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta; Atherosclerosis; CD36 Antigens; Cell Differentiation; Cell Polarity; Cyclooxygenase 2; Cytokines; Dexamethasone; Diet, Atherogenic; Dioscorea; Diosgenin; Humans; Lipoproteins, LDL; Macrophages; Male; Monocytes; Plant Extracts; Rats; Signal Transduction; THP-1 Cells; Transcription Factor RelA | 2020 |
Dioscin attenuates oxLDL uptake and the inflammatory reaction of dendritic cells under high glucose conditions by blocking p38 MAPK.
Topics: Adult; Atherosclerosis; CD36 Antigens; Dendritic Cells; Diosgenin; Female; Gene Expression Regulation; Glucose; Humans; Inflammation; Interleukin-10; Interleukin-12; Interleukin-6; Lipoproteins, LDL; Male; p38 Mitogen-Activated Protein Kinases; Scavenger Receptors, Class A; Scavenger Receptors, Class E | 2020 |
Estrogenic and anti-inflammatory effects of pseudoprotodioscin in atherosclerosis-prone mice: Insights into endothelial cells and perivascular adipose tissues.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Apoptosis; Atherosclerosis; Cells, Cultured; Chemokine CCL2; Diosgenin; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Human Umbilical Vein Endothelial Cells; Humans; Macrophages, Peritoneal; Malondialdehyde; Mice, Knockout, ApoE; Molecular Docking Simulation; Nitric Oxide Synthase Type III; Postmenopause; Tumor Necrosis Factor-alpha | 2020 |
Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats.
Topics: Animals; Atherosclerosis; Cells, Cultured; Cholesterol; Diosgenin; Foam Cells; Hyperlipidemias; Interleukin-1beta; Interleukin-6; Lipoproteins, LDL; Macrophages; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Scavenger Receptors, Class E | 2017 |
Inhibition of nuclear translocation of notch intracellular domain (NICD) by diosgenin prevented atherosclerotic disease progression.
Topics: Active Transport, Cell Nucleus; Animals; Aorta; Atherosclerosis; Cell Differentiation; Cell Line; Cell Nucleus; Diosgenin; Disease Progression; Macrophages; Male; Protein Domains; Rats; Rats, Wistar; Receptors, Notch; RNA, Messenger; Signal Transduction | 2018 |
Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; Cell Line; Cholesterol; Diosgenin; Disease Models, Animal; Dose-Response Relationship, Drug; Foam Cells; Gene Expression Regulation; Humans; Hypolipidemic Agents; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Transfection | 2015 |
Influence of different particle processing on hypocholesterolemic and antiatherogenic activities of yam (Dioscorea pseudojaponica) in cholesterol-fed rabbit model.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Anticholesteremic Agents; Aorta; Atherosclerosis; Cardiovascular Agents; Cholesterol, Dietary; Diet; Dioscorea; Diosgenin; Disease Models, Animal; Fatty Liver; Food Handling; Functional Food; Hypercholesterolemia; Liver; Male; Nanoparticles; Particle Size; Plant Preparations; Plant Tubers; Rabbits | 2013 |